Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update

被引：34
|
作者：
Giordano, Sharon H. [1 ]
Freedman, Rachel A. [2 ]
Somerfield, Mark R. [3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Amer Soc Clin Oncol, 2318 Mill Rd,Suite 800, Alexandria, VA 22314 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 03期
关键词：
D O I：
10.1200/JCO.21.02677
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options.
引用
收藏
页码：307 / +
页数：4
相关论文
共 50 条
  • [1] Adjuvant Abemaciclib Plus Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A
    Freedman, Rachel A.
    Graff, Stephanie L.
    Somerfield, Mark R.
    Telli, Melinda L.
    Wolff, Antonio C.
    Giordano, Sharon H.
    JCO ONCOLOGY PRACTICE, 2022, 18 (07) : 516 - +
  • [2] Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update
    Denduluri, Neelima
    Somerfield, Mark R.
    Chavez-MacGregor, Mariana
    Comander, Amy H.
    Dayao, Zoneddy
    Eisen, Andrea
    Freedman, Rachel A.
    Gopalakrishnan, Ragisha
    Graff, Stephanie L.
    Hassett, Michael J.
    King, Tari A.
    Lyman, Gary H.
    Maupin, Gillian Rice
    Nunes, Raquel
    Perkins, Cheryl L.
    Telli, Melinda L.
    Trudeau, Maureen E.
    Wolff, Antonio C.
    Giordano, Sharon H.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06) : 685 - +
  • [3] Abemaciclib combined with endocrine therapy for the adjuvant treatment of high-risk early breast cancer
    Johnston, Stephen R. D.
    Harbeck, Nadia
    Hegg, Roberto
    Toi, Mazakazu
    Martin, Miguel
    Shao, Zhimin
    Campone, Mario
    Hamilton, Erika
    Sohn, Joohyuk
    Guarneri, Valentina
    Cortes, Javier
    Neven, Patrick
    Boyle, Frances
    Smith, Ian C.
    Frenzel, Martin
    Headley, Desiree
    Wei, Ran
    Cox, Joanne
    O'Shaughnessy, Joyce
    Rastogi, Priya
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 112 - 113
  • [4] Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update
    Freedman, Rachel A.
    Caswell-Jin, Jennifer L.
    Hassett, Michael
    Somerfield, Mark R.
    Giordano, Sharon H.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (18) : 2233 - 2235
  • [5] Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update
    Denduluri, Neelima
    Chavez-MacGregor, Mariana
    Telli, Melinda L.
    Eisen, Andrea
    Graff, Stephanie L.
    Hassett, Michael J.
    Holloway, Jamie N.
    Hurria, Arti
    King, Tari A.
    Lyman, Gary H.
    Partridge, Ann H.
    Somerfield, Mark R.
    Trudeau, Maureen E.
    Wolff, Antonio C.
    Giordano, Sharon H.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (23) : 2433 - +
  • [6] Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
    Nina Tamirisa
    Kelly K. Hunt
    Annals of Surgical Oncology, 2022, 29 : 1489 - 1492
  • [7] Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
    Tamirisa, Nina
    Hunt, Kelly K.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (03) : 1489 - 1492
  • [8] Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
    Korde, Larissa A.
    Somerfield, Mark R.
    Carey, Lisa A.
    Crews, Jennie R.
    Denduluri, Neelima
    Hwang, E. Shelley
    Khan, Seema A.
    Loibl, Sibylle
    Morris, Elizabeth A.
    Perez, Alejandra
    Regan, Meredith M.
    Spears, Patricia A.
    Sudheendra, Preeti K.
    Symmans, W. Fraser
    Yung, Rachel L.
    Harvey, Brittany E.
    Hershman, Dawn L.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (13) : 1485 - +
  • [9] Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update Summary
    Denduluri, Neelima
    Somerfield, Mark R.
    Giordano, Sharon H.
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (08) : 508 - +
  • [10] Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-CDK4/6 Inhibitors: ASCO Rapid Guideline Update Clinical Insights
    Caswell-Jin, Jennifer L.
    Freedman, Rachel A.
    Hassett, Michael J.
    Tang, Hao
    Garrett-Mayer, Elizabeth
    Somerfield, Mark R.
    Giordano, Sharon H.
    JCO ONCOLOGY PRACTICE, 2025, 21 (03)
12345